Increased Lgals3 liver expression in steatohepatitis [112], LGALS3 plays a key role in tissue fibrosis [113]Positive association with plasma levels of galectin-3 binding protein (LGALS3BP) in NAFLD patients [104] and a subgroup with advanced fibrosis [114]. Here, LGALS3BP is linked to metabolic dysfunction-associated steatotic liver disease.